PT  - JOURNAL ARTICLE
AU  - Ayed, Mariam
AU  - Alsaffar, Zainab
AU  - Bahzad, Zainab
AU  - Buhamad, Yasmeen
AU  - Abdulkareem, Ali
AU  - AlQattan, Alaa
AU  - Embaireeg, Alia
AU  - Kartam, Mais
AU  - Alkandari, Hessa
TI  - Coronavirus infection in neonates: Neurodevelopmental outcomes at 18 months of age
AID  - 10.1101/2022.04.15.22273460
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.04.15.22273460
4099  - http://medrxiv.org/content/early/2022/04/17/2022.04.15.22273460.short
4100  - http://medrxiv.org/content/early/2022/04/17/2022.04.15.22273460.full
AB  - Background Although most neonates with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infections have mild disease, the impact on neurodevelopmental outcomes is unknown. This study aimed to assess 18-month neurodevelopmental outcomes of neonates infected with SARS-CoV-2 infection.Methods We conducted a prospective cohort study of neonates diagnosed with SARS-CoV-2 infection between June 2020–August 2020 through nasopharyngeal coronavirus disease 2019 (COVID-19) PCR testing. A total of 58 neonates were identified from the Kuwait national COVID-19 registry and were enrolled. Historical controls were selected from the neonatal follow-up registry and matched 2:1 based on sex and gestational age. At 18 months of age, neurodevelopmental outcomes were assessed using Bayley Scales of Infant and Toddler Development-3rd Edition (BSID-III) by two trained assessors.Results A total of 40 children were diagnosed with SARS-CoV-2 infection and included in the final analysis. The median age at infection was 18 days (range: 10-26 days). Eighteen (45%) were asymptomatic, 15 (37.5%) had a sepsis-like presentation, 5 (12.5%) had respiratory distress and 2 (5%) had a multisystem inflammatory syndrome in children (MIS-C)-like presentation. At 18 months follow up, only one child had severe developmental delay, and one child had a language delay. BSID-III outcomes did not significantly differ between the SARS-CoV-2 infected group and the control group.Conclusions There is no difference in neurodevelopmental outcomes in children infected with SARS-CoV-2 infection at 18 months compared to controls, although longer neurodevelopmental follow-up studies are required.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB by the Ministry of Health of Kuwait gave approval for this work number 2021-1638.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsBSID-IIIBayley Scales of Infant and Toddler Development-3rd EditionCOVID-19coronavirus disease 2019GMFCSGross Motor Function Classification SystemIQRinterquartile rangeMIS-Cmultisystem inflammatory syndrome in childrenSARS-CoV-2severe acute respiratory syndrome coronavirus-2SDstandard deviation